- Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer
Yoshihiko Tashiro et al, 2020, Scientific Reports CrossRef - In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)
Jiahui Wang et al, 2023, Cellular Oncology CrossRef - VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
Yuhui Wang et al, 2018, Molecules CrossRef - Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver
Weili Yang et al, 2018, International Journal of Molecular Sciences CrossRef - Rosuvastatin alleviated the liver ischemia reperfusion injury by activating the expression of peroxisome proliferator-activated receptor gamma (PPARγ)
Guiyuan Guo et al, 2021, Journal of Bioenergetics and Biomembranes CrossRef - PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway
Xinyu Liu et al, 2022, Journal of Investigative Surgery CrossRef - The forgotten type 2 diabetes mellitus medicine: rosiglitazone
Bo Xu et al, 2022, Diabetology International CrossRef - Use of Steatotic Grafts in Liver Transplantation: Current Status
Ana I. Álvarez‐Mercado et al, 2019, Liver Transplantation CrossRef - One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma
Hao Chen et al, 2022, Frontiers in Immunology CrossRef - Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study
Xizhu Xu et al, 2021, Complementary Therapies in Clinical Practice CrossRef - Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma
Bo Hong, 2016, World Journal of Gastroenterology CrossRef - Effect of sevoflurane pretreatment in relieving liver ischemia/reperfusion-induced pulmonary and hepatic injury
Guiping Xu et al, 2019, Acta Cirurgica Brasileira CrossRef - New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers
Yi-Fan Dang et al, 2018, Chemico-Biological Interactions CrossRef